![Lisa Bollinger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lisa Bollinger
Hoofd Techniek/Wetenschap/O&O bij
POLARYX THERAPEUTICS, INC.
Vermogen: 1 171 $ op 31-05-2026
Profiel
Lisa L.
Bollinger is an Independent Director at Apogee Therapeutics, Inc. since 2024 and Chief Medical Officer at Polaryx Therapeutics, Inc. starting in 2025.
Former roles include Associate Director-New Drug at the Center for Drug Evaluation & Research, Vice President-Global Regulatory Affairs, R&D at Amgen, Inc. from 2018 to 2021, and VP-Regulatory Affairs & Global Regulatory Affairs at Merck & Co., Inc. from 2021 to 2024.
Education includes a doctorate from Uniformed Services University of the Health Sciences and an undergraduate degree from the University of California.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 02-02-2026 | 358 ( 0% ) | 1 171 $ | 31-05-2026 | |
| 09-06-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
Actieve functies van Lisa Bollinger
| Bedrijven | Functie | Begin |
|---|---|---|
| APOGEE THERAPEUTICS, INC. | Directeur/Bestuurslid | 28-05-2024 |
| POLARYX THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-10-2025 |
Eerdere bekende functies van Lisa Bollinger
| Bedrijven | Functie | Einde |
|---|---|---|
| MERCK & CO., INC. | Algemeen Adviseur | 01-05-2024 |
| AMGEN INC. | Hoofd Techniek/Wetenschap/O&O | 01-03-2021 |
Center for Drug Evaluation & Research
 Center for Drug Evaluation & Research General GovernmentGovernment Operates agencies for the department of health and human services | Corporate Officer/Principal | - |
Opleiding van Lisa Bollinger
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
17
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Uniformed Services University of the Health Sciences
 Uniformed Services University of the Health Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Center for Drug Evaluation & Research
Center for Drug Evaluation & Research General GovernmentGovernment Operates agencies for the department of health and human services | Government |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Polaryx Therapeutics, Inc.
 Polaryx Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that engages in discovery, development and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders | Commercial Services |
Apogee Therapeutics, Inc.
 Apogee Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops therapies for immunological and inflammatory disorders | Health Technology |
